Regen BioPharma, Inc. (OTCPK: RGBP)
Health Care · Biotechnology · US
$0.00
-33.33% today · -99.5% 1Y
Regen BioPharma, Inc. (OTCPK: RGBP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $167.53K and employs 1 people.
Over the last twelve months the share price has lost 99.5%, trading between 0.00 and 0.04.
Tweenvest scores Regen BioPharma, Inc. across four factors: quality 12/100, value 55/100, growth 2/100. Its strongest factor is value.
RGBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $167.53K
- Revenue (TTM)
- $236.56K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.24
- 52-week high
- $0.04
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.68B
- Employees
- 1
- Next earnings
- —
About Regen BioPharma, Inc.
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
- ISIN
- US75886M3007
- Founded
- 2012
- Listed since
- Oct 6, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.